Weizmann Institute of Science has become the latest academic research institution to join forces with Deerfield Management for a drug discovery program.
Yeda Research and Development, the commercialisation arm of Weizmann Institute of Science, yesterday entered into a $130m partnership with healthcare-focused investment firm Deerfield Management.
The partnership, Orchard Innovations, marks Deerfield’s first outside the US where the firm has signed a string of similar initiatives, most recently launching the $130m Four Points Innovations with Duke University last month.
Orchard Innovations has been set up to back research and development projects at Weizmann through various phases of drug exploration…
